Lymphadenopathy as the first sign of human cutaneous infection by Leishmania braziliensis
- PMID: 7573708
- DOI: 10.4269/ajtmh.1995.53.256
Lymphadenopathy as the first sign of human cutaneous infection by Leishmania braziliensis
Abstract
This paper describes the presence of transitory lymphadenopathy as an initial sign of cutaneous leishmaniasis, and sometimes the only manifestation of Leishmania braziliensis infection. Ten patients with lymphadenopathy living in an area of L. braziliensis transmission had Leishmania cultivated from their lymph nodes previous to any other manifestation of cutaneous leishmaniasis. Seven of the 10 developed leishmanial ulcers later in the course of infection, whereas lymphadenopathy regressed in three cases and no other sign of infection developed. Results of tests for anti-Leishmania antibodies and an intradermal skin test were positive in four and five patients, respectively, at the time of the diagnosis. The documentation of Leishmania amastigotes in the lymph nodes before any clinical evidence of cutaneous disease indicates that early spread of L. braziliensis from the skin to lymph nodes occurs before a local lesion develops. All medical doctors examining patients coming from endemic areas of leishmaniasis should be aware that lymph node enlargement, even in the absence of a typical ulceration, may be indicative of leishmanial infection and warrants further investigation.
Similar articles
-
Bubonic leishmaniasis: a common manifestation of Leishmania (Viannia) braziliensis infection in Ceara, Brazil.Am J Trop Med Hyg. 1995 Oct;53(4):380-5. doi: 10.4269/ajtmh.1995.53.380. Am J Trop Med Hyg. 1995. PMID: 7485690
-
Cutaneous leishmaniasis associated with extensive lymphadenopathy during an epidemic in Ceará State, northeast Brazil.Acta Trop. 2005 Mar;93(3):303-10. doi: 10.1016/j.actatropica.2005.01.003. Acta Trop. 2005. PMID: 15716050
-
Lymphadenopathy associated with Leishmania braziliensis cutaneous infection.Am J Trop Med Hyg. 1992 Nov;47(5):587-92. doi: 10.4269/ajtmh.1992.47.587. Am J Trop Med Hyg. 1992. PMID: 1449199
-
Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis.Parasite Immunol. 2009 Aug;31(8):423-31. doi: 10.1111/j.1365-3024.2009.01116.x. Parasite Immunol. 2009. PMID: 19646206 Review.
-
Inflammasome Activation by CD8+ T Cells from Patients with Cutaneous Leishmaniasis Caused by Leishmania braziliensis in the Immunopathogenesis of the Disease.J Invest Dermatol. 2021 Jan;141(1):209-213.e2. doi: 10.1016/j.jid.2020.05.106. Epub 2020 Jun 13. J Invest Dermatol. 2021. PMID: 32544477 Review. No abstract available.
Cited by
-
Detection of Leishmania in unaffected mucosal tissues of patients with cutaneous leishmaniasis caused by Leishmania (Viannia) species.J Infect Dis. 2009 Aug 15;200(4):638-46. doi: 10.1086/600109. J Infect Dis. 2009. PMID: 19569974 Free PMC article.
-
The efficacy of Achilles millefolium topical gel along with intralesional injection of glucantime in the treatment of acute cutaneous leishmaniasis major.Adv Biomed Res. 2014 Mar 31;3:111. doi: 10.4103/2277-9175.129717. eCollection 2014. Adv Biomed Res. 2014. PMID: 24804185 Free PMC article.
-
Cytotoxic activity in cutaneous leishmaniasis.Mem Inst Oswaldo Cruz. 2017 Nov;112(11):733-740. doi: 10.1590/0074-02760170109. Mem Inst Oswaldo Cruz. 2017. PMID: 29091132 Free PMC article. Review.
-
Differences in gamma interferon production in vitro predict the pace of the in vivo response to Leishmania amazonensis in healthy volunteers.Infect Immun. 2001 Dec;69(12):7453-60. doi: 10.1128/IAI.69.12.7453-7460.2001. Infect Immun. 2001. PMID: 11705920 Free PMC article.
-
The Elderly Respond to Antimony Therapy for Cutaneous Leishmaniasis Similarly to Young Patients but Have Severe Adverse Reactions.Am J Trop Med Hyg. 2018 May;98(5):1317-1324. doi: 10.4269/ajtmh.17-0736. Epub 2018 Mar 22. Am J Trop Med Hyg. 2018. PMID: 29582733 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical